Scarica l'app Stockscreener
0.8101
2.60%
-0.0216
Dopo l'orario di chiusura:
.82
0.0099
+1.22%
Standard Biotools Inc Borsa (LAB) Ultime notizie
Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders? - TradingView
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Viking backs Standard BioTools (LAB) merger with Treeline Biosciences - Stock Titan
Casdin funds deepen tie to Standard BioTools (LAB) with 23.9% stake and Treeline merger support - Stock Titan
Company that shut down Peninsula HQ now swept up in reverse merger - The Business Journals
Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings - Sahm
Stealthy startup Treeline plans a reverse merger - BioPharma Dive
Standard BioTools to merge with Treeline in biotech transformation deal - The Pharma Letter
Standard BioTools Inc. (LAB) Discusses Merger and Strategic RationaleSlideshow (NASDAQ:LAB) 2026-06-08 - Seeking Alpha
Standard BioTools (LAB) Plunges Over 30%, Testing Critical Support at $0.76PCR Spike - newsline.com
Standard BioTools and Treeline Biosciences anno... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Standard BioTools and Treeline Biosciences Announce $900M Merger to Form Public Biopharma Company Focused on Oncology and Precision Medicines 12 - Minichart
Standard BioTools to Merge with Treeline Biosciences - TipRanks
Standard BioTools (NASDAQ: LAB) to merge with Treeline in $2.5B exchange‑ratio deal - Stock Titan
Standard BioTools to Merge With Treeline in All-Stock Deal Valuing Treeline at $2.5 Billion - TradingView
Treeline Biosciences, Standard BioTools (NASDAQ: LAB) plan all-stock merger - Stock Titan
Standard BioTools and Treeline Biosciences Agree to Merger, Creating Well-Funded Clinical-Stage Biopharma Company - citybiz
Standard BioTools, Treeline Biosciences to Merge in All-Stock Deal - marketscreener.com
Standard BioTools to merge with Treeline Biosciences By Investing.com - Investing.com Nigeria
Standard BioTools to merge with Treeline Biosciences - Investing.com
$900M cancer drug pipeline: Treeline, Standard BioTools to merge - Stock Titan
Standard BioTools Regains Compliance With Nasdaq's Minimum Bid Price Requirement - marketscreener.com
Standard BioTools and Treeline Biosciences Announce Merger Agreement - GlobeNewswire
Fenwick Represents Treeline Biosciences in Definitive Merger Agreement with Standard BioTools - fenwick.com
Standard BioTools Inc. 8-K Filing Details for June 5, 2026: Company Information, NASDAQ Listing, and Legal Disclosures – Minichart - Minichart
Standard BioTools Regains Nasdaq Minimum Bid Compliance Status - TipRanks
Standard BioTools regains Nasdaq bid-price compliance; matter closed - TradingView
Standard BioTools (NASDAQ: LAB) back in compliance with Nasdaq bid rule - Stock Titan
Standard BioTools Grants RSUs to Chief Business Officer - TipRanks
Standard BioTools (LAB) awards 500,000 RSUs to Chief Business Officer - Stock Titan
Standard BioTools Adopts New Executive Severance Protection Plans - TipRanks
Standard BioToolsapproves 2026 change of control and severance plan on May 21, 2026 - marketscreener.com
Standard BiotoolsApproves 2026 Change Of Control And Severance Plan On May 21, 2026 - TradingView
Standard BioTools CFO Alex Kim and CBO Sean Mackay enter 2026 Severance Plan; CEO Michael Egholm joins 2023 Plan - TradingView
Standard BioTools (LAB) sets new executive and CEO change-of-control severance terms - Stock Titan
Standard Biotools Live Share Prices and Trades. LAB.US Live Streaming Share Prices. - London South East
Standard BioTools shares hold over $1 as Nasdaq deadline nears - Bez Kabli
Standard BioTools (LAB) Hovers Near Support After Modest DeclineBlue Chip Entry Points - The Legal Advocate
Standard BioTools (LAB) Nears Support After Slight Decline Amid Cautious TradingValue Stock Ideas - The Legal Advocate
STANDARD BIOTOOLS (LAB) CFO has 18,871 shares withheld for RSU taxes - Stock Titan
Standard Biotools (LAB) SVP has 25,729 shares withheld for taxes - Stock Titan
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax obligations - Stock Titan
Standard BioTools Q1 2026 Earnings: Massive EPS Beat Fails to Lift Shares Amid Revenue UncertaintyProfit Announcement - Newser
DKSH : and Standard BioTools Announce Distribution Partnership to Expand Spatial Biology and Proteomics Solutions in Australia and New Zealand - marketscreener.com
Standard BioTools (LAB) Q1 2026 Earnings: $0.33 EPS Surges Past $-0.06 EstimatesStock Idea Hub - Newser
Standard BioTools (LAB) Q1 2026 Earnings Surprise: EPS $0.33, Up SignificantCrowd Consensus Signals - Newser
SomaLogic stock (US82489T1043): merger with Standard BioTools reshapes proteomics player - AD HOC NEWS
SomaLogic Inc stock (US82489T1043): Illumina merger closes and reshapes proteomics story - AD HOC NEWS
MAK Capital (NASDAQ: LAB) reports 6.7% stake in Standard BioTools - Stock Titan
Viking Global (LAB) holds 58.65M shares (~15%) of Standard BioTools - Stock Titan
Should You Sell Standard BioTools (LAB) After -1.52% Drop? 2026-05-15Collaborative Trading Signals - Newser
Standard BioTools (LAB) Q1 2026 Earnings: Why the Beat MattersBinary Event - newser.com
SomaLogic stock (US82489T1043): Completed $350M sale to Illumina - AD HOC NEWS
MSN Money - MSN
Standard BioTools (LAB) reports Q1 loss, tops revenue estimates - MSN
Standard BioTools Inc. (LAB) Stock Analysis: A 55% Potential Upside Beckons Investors - DirectorsTalk Interviews
2.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):